文献速递眼底病与葡萄膜炎

糖尿病视网膜病变进展中缺氧与微循环因素的评估

Evaluation of Hypoxia and Microcirculation Factors in the Progression of Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

这项回顾性纵向研究纳入82例非增殖性糖尿病视网膜病变(NPDR)患者,分为1年后无进展组(40例)和进展为增殖性糖尿病视网膜病变(PDR)组(42例)。进展组视网膜中央动脉阻力指数、缺氧指数Cg及血清HIF-1α、EPO、sICAM-1水平均显著升高,且高于无进展组。EPO超过27.5 mIU/mL时预测NPDR向PDR初期进展风险高。

要点

  • 进展组阻力指数(RI)从0.62±0.005升至0.65±0.007(P=0.003),高于无进展组(P=0.013)。
  • 进展组缺氧指数Cg为5.56±0.05,高于无进展组(P<0.001)。
  • 进展组HIF-1α、EPO、sICAM-1一年后显著升高,且高于无进展组(P<0.001)。

核心结论

  • 进展为PDR患者的胶质细胞缺氧指数Cg及血清HIF-1α、EPO水平初始即高于无进展患者,并在一年内升高,提示更严重缺氧导致PDR发生。
  • EPO超过27.5 mIU/mL时预测NPDR向PDR初期进展风险高。

研究设计与样本

  • 回顾性纵向研究,纳入82例NPDR患者,分为无进展组(n=40)和进展为PDR组(n=42)。
  • 采用多普勒超声评估眼部血流动力学,ERG计算胶质细胞缺氧指数Cg,ELISA测定血清HIF-1α、sICAM-1和EPO水平。

主要发现

  • 进展组阻力指数(RI)从0.62±0.005升至0.65±0.007(P=0.003),高于无进展组(P=0.013)。
  • 进展组缺氧指数Cg为5.56±0.05,高于无进展组(P<0.001)。
  • 进展组一年后HIF-1α为0.213±0.02 ng/mL、EPO为37.7±2.4 mIU/mL、sICAM-1为576.3±11.9 ng/mL,均较基线及无进展组显著升高(P<0.001)。
  • EPO超过27.5 mIU/mL时预测NPDR向PDR初期进展风险高。

关键数值与推荐

  • EPO超过27.5 mIU/mL时预测NPDR向PDR初期进展风险高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate comparatively the changes in HIF-1ɑ, EPO, sICAM-1, hemodynamic, and electrophysiological parameters during the progression of non-proliferative diabetic retinopathy (NPDR). METHODS: This retrospective longitudinal study included 82 patients with NPDR, who were divided into 2 groups: group I (n = 40) consisted of patients without progression of NPDR after 1 year and group II (n = 42) included patients with the transition of NPDR to proliferative diabetic retinopathy (PDR). The hemodynamics of the eye was assessed by Doppler ultrasonography. The glial hypoxia index Cg was calculated using ERG. The serum levels of hypoxia-inducible factor 1-a (HIF1-α), soluble intercellular adhesion molecule-1 (sICAM-1), and erythropoietin (EPO) were determined by ELISA method. RESULTS: In group II, resistive index (RI), short posterior ciliary arteries (SPCAs) increased significantly from 0.62 ± 0.005 to 0.65 ± 0.007 (P = 0.003), being higher than the corresponding parameter in group I (P = 0.013). In group II, there was an increase in the hypoxia index Cg (5.56 ± 0.05) relative to the primary indicators and in group I (P < 0.001). In group II, HIF1-ɑ, EPO, and sICAM-1 levels after a year significantly increased (0.213 ± 0.02 ng/mL, 37.7 ± 2.4 mIU/mL, and 576.3 ± 11.9 ng/mL, respectively) both relative to the main indicators and the values in group I (P < 0.001). When EPO exceeds 27.5 mIU/mL, a high risk of progression of NPDR to the initial stages of PDR is predicted. CONCLUSIONS: The glial Cg index and the level of HIF1-a, EPO in the serum of patients with progression of NPDR were initially higher than in patients without progression of NPDR and have increased during the year, indicating the development of PDR due to more severe hypoxia.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Majidova SR. Evaluation of Hypoxia and Microcirculation Factors in the Progression of Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2024. PMID: 38241030. doi:10.1167/iovs.65.1.35

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。